医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
HALO · HALOZYME THERAPEUTICS, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
HALOZYME THERAPEUTICS, INC.（HALO）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $22.4M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-08。
买入 Bought—
卖出 Sold$22.4M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-06 | Torley Helen Director, PRESIDENT AND CEO | 卖出 Sell | 60,000 | $110.18 | $6.6M | SEC |
| 2026-10-01 | Posard Matthew L. Director | 卖出 Sell | 5,230 | $108.54 | $568K | SEC |
| 2026-09-16 | Posard Matthew L. Director | 卖出 Sell | 18,996 | $107.74 | $2.0M | SEC |
| 2026-09-09 | Torley Helen Director, PRESIDENT AND CEO | 卖出 Sell | 60,000 | $107.28 | $6.4M | SEC |
| 2026-08-17 | Torley Helen Director, PRESIDENT AND CEO | 卖出 Sell | 60,000 | $104.59 | $6.3M | SEC |
| 2026-08-10 | Connaughton Bernadette Director | 卖出 Sell | 1,626 | $102.80 | $167K | SEC |
| 2026-07-08 | Torley Helen Director, PRESIDENT AND CEO | 卖出 Sell | 1,923 | $79.77 | $153K | SEC |
| 2026-07-01 | Connaughton Bernadette Director | 卖出 Sell | 1,625 | $76.71 | $125K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-16 | Posard Matthew L. Director | 34,226 | $3.6M | 10b5-1 |
| 2026-08-17 | Torley Helen President, CEO, Director | 240,000 | $23.7M | 10b5-1 |
| 2026-08-11 | Caudill Cortney Officer | 41,702 | $4.3M | |
| 2026-08-10 | Connaughton Bernadette Director | 1,626 | $168K | 10b5-1 |
内部人 Insiders
Torley Helen、Posard Matthew L.、Connaughton Bernadette